(Q54151779)

25 May 2018

title

PI-103 attenuates PI3K-AKT signaling and induces apoptosis in murineT-cell lymphoma. (English)

1 reference

25 May 2018

author name string

Akhilendra Kumar Maurya

series ordinal

1

1 reference

25 May 2018

Manjula Vinayak

series ordinal

2

1 reference

25 May 2018

publication date

23 September 2016

1 reference

25 May 2018

published in

Leukemia & Lymphoma

1 reference

25 May 2018

volume

58

1 reference

25 May 2018

issue

5

1 reference

25 May 2018

page(s)

1153-1161

1 reference

25 May 2018

Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Possible involvement of queuine in regulation of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Long term effect of curcumin in restoration of tumour suppressor p53 and phase-II antioxidant enzymes via activation of Nrf2 signalling and modulation of inflammation in prevention of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Long-term effect of curcumin down-regulates expression of tumor necrosis factor-α and interleukin-6 via modulation of E26 transformation-specific protein and nuclear factor-κB transcription factors in livers of lymphoma bearing mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

PI3K and AKT: Unfaithful Partners in Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Activity of any class IA PI3K isoform can sustain cell proliferation and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Critical role of PI3K signaling for NF-kappaB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

The emerging mechanisms of isoform-specific PI3K signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

The phosphoinositide 3-kinase pathway and therapy resistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

PI3K pathway alterations in cancer: variations on a theme

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Status of PI3K/Akt/mTOR pathway inhibitors in lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

PIK3CA alterations in Middle Eastern ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Frequent PIK3CA gene amplification and its clinical significance in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Cancer-derived mutations in the regulatory subunit p85alpha of phosphoinositide 3-kinase function through the catalytic subunit p110alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

PI3K inhibitors as new cancer therapeutics: implications for clinical trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Drugging the PI3 kinome: from chemical tools to drugs in the clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Evading apoptosis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

An Apoptotic 'Eat Me' Signal: Phosphatidylserine Exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Caspases and kinases in a death grip

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Involvement of PKCα activation in TF/VIIa/PAR2-induced proliferation, migration, and survival of colon cancer cell SW620.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Modulation of PKC signaling and induction of apoptosis through suppression of reactive oxygen species and tumor necrosis factor receptor 1 (TNFR1): key role of quercetin in cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Anticarcinogenic action of quercetin by downregulation of phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) via induction of p53 in hepatocellular carcinoma (HepG2) cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Testosterone exerts antiapoptotic effects against H2O2 in C2C12 skeletal muscle cells through the apoptotic intrinsic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Controlled release of drug and better bioavailability using poly(lactic acid-co-glycolic acid) nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Quercetin regresses Dalton's lymphoma growth via suppression of PI3K/AKT signaling leading to upregulation of p53 and decrease in energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Environmental neurotoxin dieldrin induces apoptosis via caspase-3-dependent proteolytic activation of protein kinase C delta (PKCdelta): Implications for neurodegeneration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Akt, FoxO and regulation of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Protein kinase Calpha: disease regulator and therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Protein kinase Cα protects against multidrug resistance in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Anti-carcinogenic action of ellagic acid mediated via modulation of oxidative stress regulated genes in Dalton lymphoma bearing mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Caspases are reversibly inactivated by hydrogen peroxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Epidemiology of lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

Protein Kinase C (PKC) Isozymes and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2016.1225207

10.1080/10428194.2016.1225207

21 January 2018

Identifiers

DOI

1 reference

25 May 2018

1 reference

25 May 2018